Skip to main content
. 2022 Nov 17;12:19730. doi: 10.1038/s41598-022-24192-8

Table 2.

Scores of EORTC QLQ-C30 and BN20 items (n = 49).

Scale Mean SD
QLQ-C30
Global health status QL2 59.9 22.3
Functional scales
Physical functioning PF2 71.2 28.8
Role functioning RF2 57.1 35.0
Emotional functioning EF 67.2 27.4
Cognitive functionin CF 63.2 33.0
Social functioning SF 55.6 38.3
Symptom scales
Fatigue FA 42.3 31.8
Nausea and vomiting NV 6.5 16.6
Pain PA 32.0 34.5
Dyspnea DY 27.9 33.6
Insomnia SL 31.3 32.2
Appetite loss AP 12.9 25.3
Constipation CO 20.1 31.9
Diarrhea DI 6.3 16.2
Financial difficulties FI 23.4 32.9
QLQ-BN20
Future uncertainty BNFU 37.9 30.5
Visual disorder BNVD 21.3 25.5
Motor dysfunction BNMD 29.5 30.1
Communication deficit BNCD 22.2 25.8
Headaches BNHA 29.3 30.9
Seizures BNSE 6.1 20.0
Drowsiness BNDR 42.2 34.5
Itchy skin BNIS 19.0 29.7
Hair loss BNHL 19.0 31.2
Weakness of legs BNWL 30.6 36.5
Bladder control BNBC 20.8 29.5

EORTC = European Organisation for Research and Treatment of Cancer; QLQ-BN20 = Quality of Life Questionnaire brain cancer module; QLQ-C30 = Core Quality of Life Questionnaire; SD = standard deviation.